We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Tess Stynes Biogen Idec Inc. (BIIB) said its treatment for hemophilia B, a rare inherited disorder that impairs blood coagulation, showed positive results in a phase three clinical study. The...
Biogen Idec Inc.'s (BIIB) second-quarter earnings fell 1.8% on acquisition-related and other charges. The biotechnology company's adjusted profit narrowly missed analysts' expectations. The...
Swedish investment company Investor AB (INVE-B.SK) Tuesday said net asset value per share as of June 30 rose 3.6% to SEK231 from the previous quarter, boosted by the sale of CaridianBCT, a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0.73 | 2.38952536825 | 30.55 | 31.28 | 30.55 | 149 | 30.91131313 | CS |
12 | 3.7431 | 13.593033348 | 27.5369 | 31.28 | 24.075 | 1150 | 26.54879116 | CS |
26 | 3.49 | 12.5584742713 | 27.79 | 31.28 | 22.87 | 1194 | 25.81181162 | CS |
52 | 10.48 | 50.3846153846 | 20.8 | 31.28 | 18.58 | 743 | 24.72281639 | CS |
156 | 3.29 | 11.7541979278 | 27.99 | 31.28 | 18.25 | 1101 | 21.81874222 | CS |
260 | 14.28 | 84 | 17 | 31.28 | 14.64 | 1200 | 21.08255652 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions